Cover Image
市場調查報告書

麴菌症:全球臨床實驗檢討

Aspergillosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 229143
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
麴菌症:全球臨床實驗檢討 Aspergillosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月17日 內容資訊: 英文 124 Pages
簡介

本報告提供麴菌症相關的臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,各地區、Phase、階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等彙整資訊。

簡介

  • 麴菌症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的被實驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 麴菌症 治療藥

有潛力的藥劑

  • 最新臨床實驗新聞: 麴菌症

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Astellas Pharma Inc.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Gilead Sciences, Inc.
    • Scynexis, Inc.
    • Novartis AG
    • Janssen Pharmaceuticals, Inc.
    • iCo Therapeutics Inc.
    • F2G Ltd
    • Eli Lilly and Company
  • 有代表性的研究機關/醫院臨床實驗概要
    • National Cancer Institute
    • Postgraduate Institute of Medical Education and Research
    • Asan Medical Center
    • Seoul National University Hospital
    • University of Cologne
    • University of Pittsburgh
    • University of Arkansas
    • Nagasaki University
    • The National Institute of Allergy and Infectious Diseases
    • PETHEMA

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2418CTIDB

GlobalData's clinical trial report, "Aspergillosis Global Clinical Trials Review, H2, 2014" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aspergillosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aspergillosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aspergillosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aspergillosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aspergillosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aspergillosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Aspergillosis
    • Sep 02, 2014: F2G announces commencement of a Phase 1 single ascending dose study of a novel antifungal agent, F901318
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Scynexis, Inc.
      • Clinical Trial Overview of Scynexis, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Janssen Pharmaceuticals, Inc.
      • Clinical Trial Overview of Janssen Pharmaceuticals, Inc.
      • iCo Therapeutics Inc.
      • Clinical Trial Overview of iCo Therapeutics Inc.
      • F2G Ltd
      • Clinical Trial Overview of F2G Ltd
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Postgraduate Institute of Medical Education and Research
      • Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • University of Arkansas
      • Clinical Trial Overview of University of Arkansas
      • Nagasaki University
      • Clinical Trial Overview of Nagasaki University
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • PETHEMA
      • Clinical Trial Overview of PETHEMA
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aspergillosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Aspergillosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Aspergillosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aspergillosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aspergillosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Aspergillosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aspergillosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aspergillosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Aspergillosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Aspergillosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aspergillosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Scynexis, Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by iCo Therapeutics Inc., 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F2G Ltd, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki University, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by PETHEMA, 2014*

List of Figures

  • Aspergillosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Aspergillosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Aspergillosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Aspergillosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Aspergillosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Aspergillosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Aspergillosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aspergillosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aspergillosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Aspergillosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aspergillosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Aspergillosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aspergillosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aspergillosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top